Samsrita Labs Ltd Stock Price Today (NSE: SAMSRITA)

Samsrita Labs Ltd

₹12.30+₹1.00 (+8.85%)
Market Closed

Fundamental Score

...

Samsrita Labs Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Samsrita Labs Ltd share price today is ₹12.30, up +8.85% on NSE/BSE as of 16 October 2026. Samsrita Labs Ltd (SAMSRITA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹27.98 (Cr). The 52-week high for SAMSRITA share price is ₹25.27 and the 52-week low is ₹10.15. The company has a Return on Equity (ROE) of -73.25% and a debt-to-equity ratio of 0.14.

Samsrita Labs Ltd Share Price Chart — NSE/BSE Historical Performance

Samsrita Labs Ltd share price chart: 0.41% return over the past month. 52-week high ₹25.27, 52-week low ₹10.15.

Samsrita Labs Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
₹11.53₹12.35₹10.81₹12.306.32K (Cr)
₹11.30₹11.30₹11.30₹11.3051.00 (Cr)
₹11.46₹11.46₹11.37₹11.37158.00 (Cr)
₹11.72₹11.72₹10.57₹11.35912.00 (Cr)
₹11.78₹11.78₹11.00₹11.432.50K (Cr)
₹11.89₹11.89₹10.73₹11.801.93K (Cr)
₹10.69₹11.18₹10.69₹11.17457.00 (Cr)
₹11.85₹11.85₹10.88₹11.24881.00 (Cr)
₹11.48₹11.48₹10.80₹11.381.68K (Cr)
₹11.99₹11.99₹11.18₹11.353.38K (Cr)

Samsrita Labs Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
₹11.54₹12.35₹10.57₹12.30+6.59%
₹12.18₹13.27₹11.11₹11.78-3.28%
₹11.17₹12.30₹10.15₹10.60-5.10%
₹11.80₹14.89₹10.56₹10.64-9.83%
₹14.75₹18.56₹11.27₹11.80-20.00%
₹17.16₹17.48₹13.38₹14.68-14.45%
₹16.65₹19.00₹14.20₹16.58-0.42%
₹17.71₹18.95₹13.78₹15.86-10.45%
₹19.49₹20.90₹15.32₹17.33-11.08%
₹20.76₹20.76₹16.85₹18.21-12.28%
₹21.85₹24.50₹19.36₹20.76-4.99%
₹22.00₹25.27₹19.07₹21.40-2.73%

Returns & Performance

Poor

Return on Equity (ROE)

-73.25%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-6.47%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Samsrita Labs Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

42.23x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

25.44%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-15.69%

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

14.87%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.14x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.86 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Samsrita Labs Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SAMSRITA across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Consistent Growth Track Record (14.87% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Conservative Debt Levels (D/E: 0.14)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

6 factors identified

Below-Average Return on Equity (-73.25%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (-6.47%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-15.69%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Negative Free Cash Flow (₹-1.86 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (25.44%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Samsrita Labs Ltd vs Healthcare Service Provider Peers

Peer Comparison - Healthcare Service Provider

Compare Samsrita Labs Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
3.9/100
₹12
₹27.98
—
-73.25%
Poor
-6.47%
Poor
0.1
Excellent
—
14.87%
Good
0.00%
69/100
₹1860
₹31171.92
44.8
Average
21.57%
Excellent
27.62%
Excellent
0.0
Excellent
11.60%
Good
11.81%
Good
0.81%
72.4/100
₹1382
₹14217.28
75.8
Average
19.74%
Good
21.32%
Excellent
0.0
Excellent
15.47%
Excellent
16.66%
Excellent
0.14%
61.7/100
₹530
₹10996.01
22.7
Average
13.36%
Average
16.80%
Good
0.0
Excellent
0.74%
Average
10.52%
Good
0.35%
70.8/100
₹485
₹7723.72
28.4
Average
28.80%
Excellent
35.47%
Excellent
0.0
Excellent
8.37%
Good
10.88%
Good
1.76%
30.4/100
₹533
₹1729.92
17.7
Average
10.89%
Average
13.05%
Average
0.5
Good
-11.13%
Poor
11.75%
Good
0.50%
68.9/100
₹307
₹1597.32
44.6
Average
14.11%
Average
16.82%
Good
0.0
Excellent
31.68%
Excellent
17.26%
Excellent
0.00%
88.2/100
₹549
₹1178.25
16.9
Average
65.27%
Excellent
87.02%
Excellent
0.0
Excellent
97.21%
Excellent
167.02%
Excellent
0.00%
54.3/100
₹1446
₹1079.13
18.4
Average
19.77%
Good
25.48%
Excellent
0.0
Excellent
-12.44%
Poor
-8.95%
Poor
0.31%
45/100
₹301
₹1035.54
539.3
Average
0.29%
Poor
-0.05%
Poor
0.0
Excellent
16.91%
Excellent
19.09%
Excellent
0.00%
48.6/100
₹238
₹600.78
20.6
Average
19.92%
Good
23.27%
Excellent
0.3
Excellent
—
—
0.00%

Samsrita Labs Ltd PE Ratio History

Historical price-to-earnings ratio for SAMSRITA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 2022₹1.01₹31.2530.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Samsrita Labs Ltd Quarterly Performance

Latest quarterly metrics for SAMSRITA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-15.69%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

14.87%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Samsrita Labs Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for SAMSRITA — calculated from daily price history

49RSI 14
Neutral — RSI 49

Momentum is balanced — neither overbought nor oversold.

SMA 50
₹12
▲ Price above SMA 50 — Short-term bullish
SMA 200
₹15
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
5K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Samsrita Labs Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Samsrita Labs Ltd (SAMSRITA) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Samsrita Labs Ltd

Loading latest quarterly results...

About SAMSRITA (Samsrita Labs Ltd)

Samsrita Labs Ltd is a pioneering healthcare service provider dedicated to revolutionizing diagnostics through advanced molecular technologies. We are committed to empowering healt...hcare professionals with precise and actionable insights, enabling personalized treatment plans and improved patient outcomes. Our state-of-the-art laboratory is equipped with cutting-edge instrumentation, allowing us to perform a comprehensive range of genetic and genomic analyses. From early disease detection to targeted therapy selection, Samsrita Labs strives to be at the forefront of diagnostic innovation, delivering reliable and timely results that contribute to better healthcare decision-making. We believe that personalized medicine is the future and we are passionate about making it accessible to all. At Samsrita Labs, our expertise lies in providing a wide spectrum of sophisticated testing services, tailored to meet the diverse needs of clinicians and patients. We specialize in advanced molecular diagnostics, offering a comprehensive suite of tests covering various disciplines. Our services include high-resolution gene sequencing, advanced molecular diagnostic assays, and cutting-edge bioinformatics analysis. Our commitment to quality and accuracy is unwavering, as we adhere to stringent quality control measures and participate in external proficiency testing programs. Our goal is to empower healthcare professionals with the tools they need to make informed decisions, leading to more effective and personalized treatments. Our extensive testing menu encompasses a broad range of applications, including personalized oncology, pharmacogenomics, infectious disease diagnostics, genetic disorder screening, transplantation compatibility testing, and prenatal genetic screening. Samsrita Labs utilizes advanced technologies such as quantitative PCR (qPCR), Sanger sequencing, and Next-Generation Sequencing (NGS) to deliver accurate and comprehensive results. We are dedicated to providing timely and reliable services, ensuring that our clients have access to the information they need to provide the best possible care. We are driven by a passion for scientific advancement and a commitment to improving the lives of patients through innovative diagnostic solutions.

Company Details

Symbol:SAMSRITA
Industry:Healthcare Service Provider
Sector:Healthcare Service Provider

Key Leadership

Mr. Konagalla Nagavenkata V. Narendra Kumar
Whole-Time Director & CFO
Srinagesh Adepu
Vice President of Operaiton
Ms. M. Gita Usha Rani
Company Secretary & Compliance Officer

SAMSRITA Share Price: Frequently Asked Questions

What is the current share price of Samsrita Labs Ltd?

Samsrita Labs Ltd (SAMSRITA) trades at ₹12.30 on NSE and BSE. Market cap ₹27.98 (Cr). Educational data only.

What is the P/E ratio of Samsrita Labs Ltd?

Samsrita Labs Ltd has a P/E of N/Ax vs industry average 42.23x.

What is the Bull Run score for Samsrita Labs Ltd?

Samsrita Labs Ltd has a Bull Run score of 3.9/100 based on 25+ financial parameters.

Does Samsrita Labs Ltd pay dividends?

Samsrita Labs Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Samsrita Labs Ltd?

Samsrita Labs Ltd has ROE of -73.25%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Samsrita Labs Ltd?

Samsrita Labs Ltd has debt-to-equity of 0.14.

Is Samsrita Labs Ltd a good investment?

Bull Run gives Samsrita Labs Ltd a score of 3.9/100. This is not investment advice — consult a SEBI-registered advisor.